International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 4 , Pages 1147-1153 , 15 March 2010

Primary Tumor Necrosis Predicts Distant Control in Locally Advanced Soft-Tissue Sarcomas After Preoperative Concurrent Chemoradiotherapy

Presented at the 50th Annual Meeting of the American Society for Therapeutic Radiology and Oncology in Boston, MA, Sept. 21–25, 2008.

  • Dhara M. MacDermed, M.D.

      Affiliations

    • Department of Radiation & Cellular Oncology, University of Chicago, Chicago, IL
    • ,
  • Luke L. Miller, B.S.

      Affiliations

    • Pritzker School of Medicine, University of Chicago, Chicago, IL
    • ,
  • Terrance D. Peabody, M.D.

      Affiliations

    • Section of Orthopaedic Surgery and Rehabilitation, Department of Surgery, University of Chicago, Chicago, IL
    • ,
  • Michael A. Simon, M.D.

      Affiliations

    • Section of Orthopaedic Surgery and Rehabilitation, Department of Surgery, University of Chicago, Chicago, IL
    • ,
  • Hue H. Luu, M.D.

      Affiliations

    • Section of Orthopaedic Surgery and Rehabilitation, Department of Surgery, University of Chicago, Chicago, IL
    • ,
  • Rex C. Haydon, M.D., Ph.D.

      Affiliations

    • Section of Orthopaedic Surgery and Rehabilitation, Department of Surgery, University of Chicago, Chicago, IL
    • ,
  • Anthony G. Montag, M.D.

      Affiliations

    • Department of Pathology, University of Chicago, Chicago, IL
    • ,
  • Samir D. Undevia, M.D.

      Affiliations

    • Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
    • ,
  • Philip P. Connell, M.D.

      Affiliations

    • Department of Radiation & Cellular Oncology, University of Chicago, Chicago, IL
    • Corresponding Author InformationReprint requests to: Philip P. Connell, M.D., Department of Radiation & Cellular Oncology, University of Chicago Hospitals, 5758 S. Maryland Ave., MC 9006, Chicago, IL 60637. Tel: (773) 702-6870; Fax: (773) 834-7340

Received 9 February 2009 ,Revised 7 March 2009 ,Accepted 13 March 2009.

References 

  1. Zahm SH, Fraumeni JF. The epidemiology of soft tissue sarcoma. Semin Oncol. 1997;24:504–514
  2. Coindre JM, Terrier P, Guillou L, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: A study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer. 2001;91:1914–1926
  3. Heise HW, Myers MH, Russell WO, et al. Recurrence-free survival time for surgically treated soft tissue sarcoma patients. Multivariate analysis of five prognostic factors. Cancer. 1986;57:172–177
  4. Suit HD, Mankin HJ, Wood WC, et al. Preoperative, intraoperative, and postoperative radiation in the treatment of primary soft tissue sarcoma. Cancer. 1985;55:2659–2667
  5. Rosenberg SA, Tepper J, Glatstein E, et al. The treatment of soft-tissue sarcomas of the extremities: Prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg. 1982;196:305–315
  6. Harrison LB, Franzese F, Gaynor JJ, et al. Long-term results of a prospective randomized trial of adjuvant brachytherapy in the management of completely resected soft tissue sarcomas of the extremity and superficial trunk. Int J Radiat Oncol Biol Phys. 1993;27:259–265
  7. Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998;16:197–203
  8. Pollack A, Zagars GK, Goswitz MS, et al. Preoperative vs. postoperative radiotherapy in the treatment of soft tissue sarcomas: A matter of presentation. Int J Radiat Oncol Biol Phys. 1998;42:563–572
  9. Mundt AJ, Awan A, Sibley GS, et al. Conservative surgery and adjuvant radiation therapy in the management of adult soft tissue sarcoma of the extremities: Clinical and radiobiological results. Int J Radiat Oncol Biol Phys. 1995;32:977–985
  10. Davis AM, O'Sullivan B, Turcotte R, et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol. 2005;75:48–53
  11. O'Sullivan B, Davis A, Turcotte R, et al. Five-year results of a randomized phase III trial of pre-operative vs post-operative radiotherapy in extremity soft tissue sarcoma. Presented at the Annual Meeting of the America Society of Clinical Oncology, held June 5-8, 2004 in New Orleans. J Clin Oncol. 2004;22:9007
  12. Gortzak E, Azzarelli A, Buesa J, et al. A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma. Eur J Cancer. 2001;37:1096–1103
  13. Grobmyer SR, Maki RG, Demetri GD, et al. Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma. Ann Oncol. 2004;15:1667–1672
  14. Eilber FC, Rosen G, Eckardt J, et al. Treatment-induced pathologic necrosis: A predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol. 2001;19:3203–3209
  15. Eilber FR, Morton DL, Eckardt J, et al. Limb salvage for skeletal and soft tissue sarcomas. Multidisciplinary preoperative therapy. Cancer. 1984;53:2579–2584
  16. Eilber FR, Giuliano AE, Huth JF, Weisenburger TH, Eckhardt J. Intravenous (IV) vs. intraarterial (IA) Adriamycin, 2800r radiation and surgical excision for extremity soft tissue sarcomas: A randomized prospective trial (Abstract). Proc Am Soc Clin Oncol. 1990;9:309a
  17. Wanebo HJ, Temple WJ, Popp MB, et al. Preoperative regional therapy for extremity sarcoma. A tricenter update. Cancer. 1995;75:2299–2306
  18. DeLaney TF, Spiro IJ, Suit HD, et al. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys. 2003;56:1117–1127
  19. Kraybill WG, Harris J, Spiro IJ, et al. Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514. J Clin Oncol. 2006;24:619–625
  20. Ryan CW, Montag AG, Hosenpud JR, et al. Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas. Cancer. 2008;112:2432–2439
  21. Mack LA, Crowe PJ, Yang JL, et al. Preoperative chemoradiotherapy (modified Eilber protocol) provides maximum local control and minimal morbidity in patients with soft tissue sarcoma. Ann Surg Oncol. 2005;12:646–653
  22. Levine EA, Trippon M, Das Gupta TK. Preoperative multimodality treatment for soft tissue sarcomas. Cancer. 1993;71:3685–3689
  23. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: Meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet. 1997;350:1647–1654
  24. Lorigan P, Verweij J, Papai Z, et al. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol. 2007;25:3144–3150
  25. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481
  26. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163–170
  27. Choong PF, Nizam I, Ngan SY, et al. Thallium-201 scintigraphy—A predictor of tumour necrosis in soft tissue sarcoma following preoperative radiotherapy?. Eur J Surg Oncol. 2003;29:908–915
  28. O'Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: A randomised trial. Lancet. 2002;359:2235–2241
  29. Hall EJ. Radiobiology for the radiologist. 5th ed.. Philadelphia: Lippincott Williams & Wilkins; 2000;
  30. Kane JM, Harris J, Kraybill WG, et al. RTOG 0330: A pilot phase II study of preoperative radiation therapy/thalidomide for low-grade primary soft tissue sarcoma or preoperative MAID/thalidomide/radiation therapy for high/intermediate grade primary soft tissue sarcoma of the extremity or body wall. Presented at the Annual Meeting of the America Society of Clinical Oncology, held May 30-June 3, 2008 in Chicago. J Clin Oncol. 2008;26(suppl):10536;(Abstract)

 D.M.M. and L.L.M. contributed equally to this work.

 Conflict of interest: none.

PII: S0360-3016(09)00442-8

doi: 10.1016/j.ijrobp.2009.03.015

International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 4 , Pages 1147-1153 , 15 March 2010

Article Tools

* Image Usage & Resolution